These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3996088

  • 1. Susceptibility of Candida spp. of clinical origin to lucknomycin, a new polyenic antibiotic.
    Sousa AS, Gómez-Criado C, Baquero F.
    Chemotherapy; 1985; 31(3):211-5. PubMed ID: 3996088
    [Abstract] [Full Text] [Related]

  • 2. Minimal inhibitory concentrations of lucknomycin, a new polyenic derivative, for Candida and Aspergillus spp.
    Martínez-Quesada J, Torres-Rodriguez JM, Rosés-Codinachs M, Amaral-Olivera M.
    Antimicrob Agents Chemother; 1983 Jul; 24(1):132-3. PubMed ID: 6625552
    [Abstract] [Full Text] [Related]

  • 3. [Sensitivity of yeasts of the genus Candida to new antifungal agents].
    Hernández-Molina JM, Llosá J, Martínez-Brocal A, de la Rosa M.
    Enferm Infecc Microbiol Clin; 1991 Jul; 9(7):405-8. PubMed ID: 1799609
    [Abstract] [Full Text] [Related]

  • 4. [The sensitivity of yeasts from the Candida genus isolated from cancer patients to polyene antifungals].
    Alves SH, Cury AE.
    Rev Inst Med Trop Sao Paulo; 1992 Jul; 34(3):251-4. PubMed ID: 1342079
    [Abstract] [Full Text] [Related]

  • 5. Antifungal activity of LY295337 in vitro against clinical isolates of Candida spp.
    Aller AI, Martin Mazuelos E, Morilla MD, Montero O.
    Chemotherapy; 1995 Jul; 41(4):276-80. PubMed ID: 7555208
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility of Candida species strains to five antifungal agents: comparison between agar dilution and disk diffusion tests.
    Trancassini M, Ghezzi MC, Cipriani P, Mancini C, Brenciaglia MI.
    Chemioterapia; 1986 Feb; 5(1):14-7. PubMed ID: 3955776
    [Abstract] [Full Text] [Related]

  • 7. [A comparative study between broth dilution and agar dilution technics in antibiograms for Candida].
    Alves SH, Cury AE.
    Rev Inst Med Trop Sao Paulo; 1992 Feb; 34(3):259-62. PubMed ID: 1342081
    [Abstract] [Full Text] [Related]

  • 8. [Anti-amebic effect of polyenic antibiotics].
    Liubimova LK, Ovnanian KO, Ivanova LN.
    Antibiot Med Biotekhnol; 1985 Mar; 30(3):179-82. PubMed ID: 2861787
    [Abstract] [Full Text] [Related]

  • 9. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E, Parras P, Lozano MC.
    Chemotherapy; 1992 Mar; 38(5):335-9. PubMed ID: 1337508
    [Abstract] [Full Text] [Related]

  • 10. Effects of two different growth media on the postantifungal effect induced by polyenes on Candida species.
    Shu M, Ellepola AN, Samaranayake LP.
    J Clin Microbiol; 2001 Jul; 39(7):2732-5. PubMed ID: 11427609
    [Abstract] [Full Text] [Related]

  • 11. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F, Benderdouche M, Sednaoui P.
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK, Mutlu B, Dündar D, Willke A.
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [Abstract] [Full Text] [Related]

  • 13. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M, Bastide JM, Blancard A, Bonnin A, Bretagne S, Cambon M, Chandenier J, Chauveau V, Couprie B, Datry A, Feuilhade M, Grillot R, Guiguen C, Lavarde V, Letscher V, Linas MD, Michel A, Morin O, Paugam A, Piens MA, Raberin H, Tissot E, Toubas D, Wade A.
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [Abstract] [Full Text] [Related]

  • 14. Synergistic fungicidal activity of the lipopeptide bacillomycin D with amphotericin B against pathogenic Candida species.
    Tabbene O, Di Grazia A, Azaiez S, Ben Slimene I, Elkahoui S, Alfeddy MN, Casciaro B, Luca V, Limam F, Mangoni ML.
    FEMS Yeast Res; 2015 Jun; 15(4):fov022. PubMed ID: 25956541
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
    Kaynak Onurdağ F, Ozgen S, Abbasoğlu U, Gürcan IS.
    Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
    [Abstract] [Full Text] [Related]

  • 16. Characteristics of certain features of Candida strains with reduced nystatin sensitivity and assessment of the activity of new derivatives of nystatin and polyfungin against these strains.
    Kwaśniewska J.
    Mater Med Pol; 1988 Oct; 20(4):239-41. PubMed ID: 3249542
    [No Abstract] [Full Text] [Related]

  • 17. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.
    Sehgal SN, Baker H, Vézina C.
    J Antibiot (Tokyo); 1975 Oct; 28(10):727-32. PubMed ID: 1102509
    [Abstract] [Full Text] [Related]

  • 18. [In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
    Batura-Gabryel H, Wieczorek U, Mlynarczyk W.
    Pneumonol Alergol Pol; 1997 Oct; 65(5-6):355-9. PubMed ID: 9340063
    [Abstract] [Full Text] [Related]

  • 19. Antimycotic activity in vitro and in vivo of a new hydrosoluble polyene antibiotic.
    Strippoli V, Evangelista AM, Simonetti N.
    Farmaco Sci; 1976 Dec; 31(12):891-900. PubMed ID: 1017483
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of a new automated system for the determination of antifungal sensitivity].
    Lozano MC, Parras P, Martín E.
    Enferm Infecc Microbiol Clin; 1993 Mar; 11(3):135-8. PubMed ID: 8499512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.